Chris Willis

Title: Chris Willis: Innovator in Pharmaceutical Applications

Introduction

Chris Willis is a notable inventor based in Southborough, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit glucosylceramide synthase. With a total of 2 patents, his work is paving the way for advancements in treating various diseases.

Latest Patents

Willis's latest patents include innovative formulations of the hemitartrate salt of a compound represented by a specific structural formula. These formulations may be utilized in pharmaceutical applications. The patents detail particular single crystalline forms of the Formula (I) Hemitartrate, characterized by a variety of properties and physical measurements. Additionally, methods for producing crystalline Formula (I) Hemitartrate and its application in inhibiting glucosylceramide synthase or lowering glycosphingolipid concentrations in subjects are discussed. The patents also describe pharmaceutical compositions that leverage these compounds.

Career Highlights

Chris Willis is currently employed at Genzyme Corporation, where he continues to focus on pharmaceutical innovations. His work has been instrumental in developing new therapeutic options for patients suffering from diseases related to glycosphingolipid concentrations.

Collaborations

Willis collaborates with talented coworkers, including Hanlan Liu and Renu Bhardwaj, who contribute to the research and development efforts at Genzyme Corporation.

Conclusion

Chris Willis is a prominent inventor whose work in pharmaceutical applications is making a significant impact in the medical field. His innovative patents and collaborations are essential for advancing treatments for various diseases.